<DOC>
	<DOCNO>NCT00968695</DOCNO>
	<brief_summary>Pharmacodynamic study pathophysiological nature ass effect prolong administration human albumin cardiocirculatory renal function hepatic hemodynamics patient advanced cirrhosis ascites .</brief_summary>
	<brief_title>Clinical Trial Effects Long Term Administration 20 % Albumin Cardiovascular Renal Function , And Hepatic Hemodynamics Advanced Patients With Cirrhosis Ascites .</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<criteria>Age 18 year less 80 year . Diagnosis liver cirrhosis biopsy clinical , laboratory , ultrasound . Daily requirement diuretic least 200mg spironolactone 100mg spironolactone 40 mg furosemide Renal dysfunction define plasma concentration serum creatinine ≥ 1.2 mg / dl , BUN ≥ 25 mg / dl serum sodium concentration ≤ 130 mEq / L. Refractory Ascites ( paracentesis requirement 1 month . Neoplastic disease include liver cancer exceed Milan criterion ( one nodule &gt; 5 cm three nodule &gt; 3 cm ) . History transjugular intrahepatic portosystemic shunt ( TIPS ) surgical shunt Gastrointestinal bleeding bacterial infection document past 15 day . Heart failure structural heart disease . Organic renal insufficiency ( proteinuria , hematuria / ultrasound data nephropathy ) . Moderate severe lung chronic disease . Transplant . Infection human immunodeficiency virus . Active addiction drug . Mental state prevents patient understand nature , extent consequence study , except hepatic encephalopathy . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>